The increase in price target by Piper Sandler suggests a positive outlook on Alnylam Pharmaceuticals' stock, which could lead to a short-term increase in its stock price. Analyst ratings and price target adjustments are significant factors that investors consider when making investment decisions. The Overweight rating indicates that the analyst believes the stock will outperform the average return of the stocks in the analyst's coverage universe.